Aptose Biosciences, Inc. (APS.TO)

2.35 -0.04 (-1.67%) CAD  |  TSX  |  Apr 02, 16:00
More

Aptose Biosciences Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for APS.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Arch Biopartners, Inc. Upgrade
MedMira, Inc. Upgrade
Innovotech, Inc. Upgrade
Entheon Biomedical Corp. Upgrade
Marvel Biosciences Corp. --

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Return on Invested Capital Upgrade